Yu H - Search Results

1

Molecular principle of topotecan resistance by topoisomerase I mutations through molecular modeling approaches.

Pan P, Li Y, Yu H, Sun H, Hou T. Pan P, et al. Among authors: yu h. J Chem Inf Model. 2013 Apr 22;53(4):997-1006. doi: 10.1021/ci400066x. Epub 2013 Apr 3. J Chem Inf Model. 2013. PMID: 23521602

2

ADMET evaluation in drug discovery. 11. PharmacoKinetics Knowledge Base (PKKB): a comprehensive database of pharmacokinetic and toxic properties for drugs.

Cao D, Wang J, Zhou R, Li Y, Yu H, Hou T. Cao D, et al. Among authors: yu h. J Chem Inf Model. 2012 May 25;52(5):1132-7. doi: 10.1021/ci300112j. Epub 2012 May 15. J Chem Inf Model. 2012. PMID: 22559792

3

Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations.

Jin Y, Duan M, Wang X, Kong X, Zhou W, Sun H, Liu H, Li D, Yu H, Li Y, Hou T. Jin Y, et al. Among authors: yu h. J Chem Inf Model. 2019 Feb 25;59(2):842-857. doi: 10.1021/acs.jcim.8b00796. Epub 2019 Feb 6. J Chem Inf Model. 2019. PMID: 30658039

4

Recent developments of in silico predictions of oral bioavailability.

Zhu J, Wang J, Yu H, Li Y, Hou T. Zhu J, et al. Among authors: yu h. Comb Chem High Throughput Screen. 2011 Jun 1;14(5):362-74. doi: 10.2174/138620711795508368. Comb Chem High Throughput Screen. 2011. PMID: 21470180 Review.

5

Computational models for predicting substrates or inhibitors of P-glycoprotein.

Chen L, Li Y, Yu H, Zhang L, Hou T. Chen L, et al. Among authors: yu h. Drug Discov Today. 2012 Apr;17(7-8):343-51. doi: 10.1016/j.drudis.2011.11.003. Epub 2011 Nov 18. Drug Discov Today. 2012. PMID: 22119877 Review.

6

Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses.

Zhu J, Li Y, Yu H, Zhang L, Mao X, Hou T. Zhu J, et al. Among authors: yu h. Comb Chem High Throughput Screen. 2012 Jul;15(6):439-50. doi: 10.2174/138620712800563918. Comb Chem High Throughput Screen. 2012. PMID: 22263860

7

Discovery of Rho-kinase inhibitors by docking-based virtual screening.

Shen M, Yu H, Li Y, Li P, Pan P, Zhou S, Zhang L, Li S, Lee SM, Hou T. Shen M, et al. Among authors: yu h. Mol Biosyst. 2013 Jun;9(6):1511-21. doi: 10.1039/c3mb00016h. Epub 2013 Apr 3. Mol Biosyst. 2013. PMID: 23549429

8

Advances in the development of Rho-associated protein kinase (ROCK) inhibitors.

Pan P, Shen M, Yu H, Li Y, Li D, Hou T. Pan P, et al. Among authors: yu h. Drug Discov Today. 2013 Dec;18(23-24):1323-33. doi: 10.1016/j.drudis.2013.09.010. Epub 2013 Sep 25. Drug Discov Today. 2013. PMID: 24076262 Review.

9

Farnesyltransferase and geranylgeranyltransferase I: structures, mechanism, inhibitors and molecular modeling.

Shen M, Pan P, Li Y, Li D, Yu H, Hou T. Shen M, et al. Among authors: yu h. Drug Discov Today. 2015 Feb;20(2):267-76. doi: 10.1016/j.drudis.2014.10.002. Epub 2014 Oct 16. Drug Discov Today. 2015. PMID: 25450772 Review.

10

In Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: The Performance of Different Selection Strategy in Selecting Virtual Screening Candidates.

Pan P, Sun H, Liu H, Li D, Zhou W, Kong X, Li Y, Yu H, Hou T. Pan P, et al. Among authors: yu h. Sci Rep. 2016 Nov 23;6:37628. doi: 10.1038/srep37628. Sci Rep. 2016. PMID: 27876862 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,685 results

Search Page

Filters